Back to search

France· FR:65832685

TOBI 300 mg/5 ml, solution pour inhalation par nébuliseur

A medicinal product containing tobramycine, registered in France by VIATRIS MEDICAL, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedTOBI 300 mg/5 ml, solution pour inhal…ATC—REGISTER NO.FR:65832685PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
TOBRAMYCINE
Manufacturer
VIATRIS MEDICAL
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400936572324
    56 ampoule(s) polyéthylène de 5 ml
    EUR 2.1

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tobramycine in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tobramycine products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Bramitob, Tobi
  • Belgium · Obracin, Tobi
  • Bulgaria · Tобрекс, Тобрамизил
  • Cyprus · Bramitob, Ikobel
  • Czechia · Bramitob, Tobramycin Vioser
  • Germany · Bramitob, Gernebcin
  • Denmark · Nebcina, Tobi
  • Estonia · Tobramycin Via Pharma, Tobrex
  • Spain · Bramitob, Tobrabact
  • Finland · Tobi
  • United Kingdom (Northern Ireland) · Bramitob, Munuza
  • Greece · Bramitob, Eyetobrin
  • Croatia · Bramitob, Tobrex
  • Hungary · Bramitob, Brulamycin
  • Ireland · Bramitob, Tobi
  • Iceland · Tobi Podhaler, Vantobra
  • Italy · Bramicil, Bramitob
  • Liechtenstein · Tobi Podhaler, Vantobra
  • Lithuania · Bramitob, Tobramycin Via Pharma
  • Luxembourg · Obracin, Tobi
  • Latvia · Bramitob, Tobramycin Via Pharma
  • Malta · Tobi, Tobrex
  • Netherlands · Bramitob, Obracin
  • Norway · Bramitob, Nebcina
  • Poland · Bramitob, Tobramycin Via Pharma
  • Portugal · Bramitob, Tobi
  • Romania · Tobi, Tobramicină Sun
  • Sweden · Bramitob, Nebcina
  • Slovenia · Tobrex
  • Slovakia · Bramitob, Tobrex

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8ac261dd-d93d-4630-9170-513161b37c16
GET /v1/drugs/8ac261dd-d93d-4630-9170-513161b37c16?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "65832685",
  "date_amm": "2000-11-21",
  "type_amm": "Procédure de reconnaissance mutuelle",
  "numero_ue": null,
  "substance": "TOBRAMYCINE",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "solution pour inhalation par nébuliseur",
  "voies_administration": "inhalée",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about tobramycine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.